Internal Medicine, Critical Care Medicine · Austin, TX
NPI
1023221959
Since 2007
Specialty
Internal Medicine, Critical Care Medicine
Code 207RC0200X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
3600 W Parmer Ln, Suite 106
Austin, TX, 78727
Phone (512) 977-0123
Groups this clinician bills Medicare through
Medicare paid, 2024
$212K
3,726 services
Medicare patients, 2024
630
Average age 75
Drug cost, 2024
$1.7M
3,414 prescriptions
Company payments, 2025
$12K
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Matthew A Anderson was code 99214 (office e&m - established), 798 times for 378 patients. In total Matthew A Anderson billed 3,726 services in 37 codes, and Medicare paid $212K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-10-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 798 | 378 | $93.02 | $74K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 578 | 179 | $49.56 | $29K |
| 94375 Pulmonary Function Testing | Office | 354 | 291 | $29.41 | $10K |
| 99457 E&M - Miscellaneous | Office | 275 | 71 | $39.23 | $11K |
| 99454 E&M - Miscellaneous | Office | 260 | 75 | $38.47 | $10K |
| 94726 Pulmonary Function Testing | Office | 256 | 229 | $42.28 | $11K |
| 94729 Pulmonary Function Testing | Office | 223 | 204 | $42.07 | $9,381 |
| 99458 E&M - Miscellaneous | Office | 143 | 57 | $31.38 | $4,488 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 123 | 64 | $38.39 | $4,722 |
| 99213 Office E&M - Established | Office | 107 | 93 | $65.89 | $7,050 |
| 99232 Hospital E&M - Subsequent | Facility | 102 | 55 | $60.64 | $6,185 |
| 99204 Office E&M - New | Office | 85 | 85 | $122.72 | $10K |
| 94375 Pulmonary Function Testing | Facility | 38 | 38 | $11.05 | $420 |
| 94729 Pulmonary Function Testing | Facility | 36 | 36 | $6.83 | $246 |
| 99233 Hospital E&M - Subsequent | Facility | 33 | 30 | $87.02 | $2,872 |
By year: 2022 $157K for 2,292 services; 2023 $168K for 2,643 services; 2024 $212K for 3,726 services.
Medicare prescription drug claims, 2024
In 2024, the drug Matthew A Anderson prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 424 prescriptions and refills. In total Matthew A Anderson wrote 3,414 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 424 | 896 | 119 | $551K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 420 | 666 | 188 | $17K |
| Prednisone Generic | 379 | 464 | 154 | $1,476 |
| Azithromycin Generic | 277 | 491 | 122 | $2,770 |
| Montelukast Sodium Generic | 191 | 516 | 62 | $2,941 |
| Breo Ellipta Fluticasone/Vilanterol | 153 | 309 | 52 | $115K |
| Spiriva Respimat Tiotropium Bromide | 86 | 158 | 28 | $77K |
| Arnuity Ellipta Fluticasone Furoate | 79 | 127 | 31 | $29K |
| Ipratropium Bromide Generic | 73 | 121 | 40 | $1,589 |
| Roflumilast Generic | 66 | 93 | 14 | $4,914 |
| Mycophenolate Mofetil Generic | 65 | 115 | 14 | $8,349 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 62 | 62 | 41 | $503 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 57 | 119 | 20 | $16K |
| Advair Hfa Fluticasone Propion/Salmeterol | 51 | 85 | 16 | $33K |
| Fluticasone Propionate Generic | 51 | 106 | 25 | $1,149 |
Brand drugs: 1,537 claims; generic drugs: 1,877 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Matthew A Anderson $12K ($12K in general payments such as food, travel and fees) from 6 companies. The largest payer was Ethicon Endo-Surgery Inc. with $9,635.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.